We are live on ! Find out more
TGA

TPG GP A Portfolio holdings

AUM $3.68B
1-Year Est. Return 14.99%
This Fund
S&P 500
This Quarter Est. Return
-4.29%
1 Year Est. Return
+14.99%
3 Year Est. Return
+76.26%
5 Year Est. Return
10 Year Est. Return
AUM
$3.68B
AUM Growth
+$992M
Cap. Flow
+$1.33B
Cap. Flow %
36.22%
Top 10 Hldgs %
76.38%
Holding
76
New
66
Increased
Reduced
3
Closed

Top Sells

Rank Stock Value
1
LFST icon
Lifestance Health
LFST
+$144M
2
SION
Sionna Therapeutics
SION
+$9.54M
3
RLYB icon
Rallybio
RLYB
+$7

Sector Composition

Rank Sector Weight
1 Healthcare 40.79%
2 Financials 13.63%
3 Consumer Discretionary 13.06%
4 Industrials 9.96%
5 Energy 1.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFST icon
1
Lifestance Health
LFST
$4.33B
$892M 24.25%
140,026,557
-20,685,061
-13% -$144M
JXN icon
2
Jackson Financial
JXN
$8.58B
$499M 13.55%
+4,715,554
New +$527M
LTH icon
3
Life Time Group Holdings
LTH
$9.46B
$480M 13.06%
17,830,652
SION
4
Sionna Therapeutics
SION
$2.06B
$260M 7.08%
6,494,962
-250,000
-4% -$9.54M
BETA
5
Beta Technologies Inc
BETA
$4.53B
$241M 6.55%
16,395,435
AMRX icon
6
Amneal Pharmaceuticals
AMRX
$5.59B
$153M 4.17%
12,328,767
NGL icon
7
NGL Energy Partners
NGL
$1.92B
$73.2M 1.99%
+5,934,493
New +$67.4M
CBLL
8
CeriBell Inc
CBLL
$699M
$72.7M 1.98%
3,967,422
NVRI icon
9
Enviri
NVRI
$621M
$70.9M 1.93%
+3,613,688
New +$67.1M
BCAX
10
Bicara Therapeutics
BCAX
$1.78B
$59.9M 1.63%
3,010,425
BRKRP
11
Bruker Corporation 6.375% Series A Preferred Stock
BRKRP
$1.2B
$47M 1.28%
+163,000
New +$53.2M
ALLO icon
12
Allogene Therapeutics
ALLO
$611M
$45.7M 1.24%
18,716,306
HPE.PRC
13
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$3.48B
$37.3M 1.01%
+575,000
New +$35.3M
NX icon
14
Quanex
NX
$811M
$36.9M 1%
+2,054,770
New +$38.8M
NOVTU
15
Novanta Inc Units
NOVTU
$678M
$35.4M 0.96%
+661,667
New +$38.5M
PCG.PRX
16
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.38B
$29.3M 0.8%
+680,000
New +$28.9M
NEE.PRV
17
NextEra Energy Inc 7.375% Corporate Units
NEE.PRV
$28.8M 0.78%
+575,000
New +$28.7M
APO.PRA icon
18
Apollo Global Management Series A
APO.PRA
$1.72B
$19.1M 0.52%
+325,000
New +$21.1M
PPLC
19
PPL Corp Corporate Units
PPLC
$18.9M 0.51%
+370,000
New +$18.8M
TRTX
20
TPG RE Finance Trust
TRTX
$670M
$18.7M 0.51%
2,392,863
ARES.PRB
21
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.19B
$15.5M 0.42%
+419,500
New +$18M
EA icon
22
Electronic Arts
EA
$52.5B
$13.3M 0.36%
+65,000
New +$13.1M
NSC icon
23
Norfolk Southern
NSC
$75.2B
$11.5M 0.31%
+40,000
New +$11.9M
ORCL.PRD
24
Oracle Corp Preferred Stock Series D
ORCL.PRD
$10.3M 0.28%
+225,000
New +$10.6M
CWAN
25
DELISTED
Clearwater Analytics
CWAN
$9.11M 0.25%
+385,000
New +$9.11M

Similar funds

TPG GP A's Q1 2026 Portfolio in Review

As of Q1 2026, TPG GP A held 76 positions worth $3.68B, up 37% from $2.69B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

TPG GP A deployed $1.33B of net new capital in Q1 2026, opening 66 new positions. Its largest new stake was Jackson Financial: 4,715,554 shares worth $499M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 64% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Lifestance Health, an estimated $144M trimmed.

  • TPG GP A's largest Q1 2026 buy was Jackson Financial: 4,715,554 shares worth $499M.
  • TPG GP A's biggest Q1 2026 reduction was Lifestance Health, cutting an estimated $144M.
  • TPG GP A's ten largest holdings make up 76% of its $3.68B portfolio in Q1 2026.
  • TPG GP A opened 66 new positions and closed 0 in Q1 2026.
  • TPG GP A's portfolio value rose 37% quarter-over-quarter to $3.68B.

Based on TPG GP A's 13F filing for Q1 2026, filed 15 May 2026.